Table 3.
RIL | Trait | QTL | Chr | Pos (cM) | Physical Range (bp) | Flanking Marker | Additive Effect | AE Effect | Ref | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | PVE (%) | AE1 | AE2 | AE3 | PVE (%) | ||||||||
ZY | SL | qSL-4-2ZY | 4 | 39.22 | 19283057–19438579 | Mark386837–Mark359625 | 0.18 | 22.47 | NS | NS | NS | 0 | [3] |
qSL-6-1ZY | 6 | 65.93 | 18831802–19024597 | Mark750099–Mark741078 | 0.09 | 6.04 | NS | NS | NS | 1.69 | [32] | ||
qSL-9-2ZY | 9 | 82.03 | 39583668–39417035 | Mark596882–Mark570229 | 0.08 | 3.89 | NS | NS | NS | 0 | THIS STUDY | ||
qSL-13-3ZY | 13 | 78.75 | 31540635–31390215 | Mark473668–Mark478524 | 0.08 | 4.65 | −0.03 ** | 0.03 ** | NS | 0.82 | [3] | ||
qSL-13-4ZY | 13 | 4.001 | 13278146–14133381 | Mark471284–Mark486987 | 0.06 | 2.62 | 0.02 ** | −0.01 * | −0.01 * | 0.45 | [3] | ||
qSL-14-2ZY | 14 | 12.14 | 47107927–47737451 | Mark941949–Mark890565 | −0.08 | 3.97 | 0.01 ** | NS | −0.01 * | 0.11 | THIS STUDY | ||
qSL-15-1ZY | 15 | 30.54 | 7595034–8201285 | Mark817834–Mark818425 | 0.07 | 2.89 | NS | NS | NS | 0.04 | [3] | ||
qSL-17-2ZY | 17 | 54.6 | 13439080–13701008 | Mark96769–Mark84717 | 0.06 | 2.61 | NSN | NS | NS | 0 | [34] | ||
SW | qSW-1-2ZY | 1 | 67.22 | 17489394–20846299 | Mark974988–Mark977669 | 0.03 | 1.69 | NS | 0.03 ** | −0.04 ** | 2.78 | THIS STUDY | |
qSW-1-1ZY | 1 | 100.2 | 51095466–51296512 | Mark1014325–Mark988734 | 0.14 | 29.35 | NS | NS | NS | 0 | THIS STUDY | ||
qSW-4-1ZY | 4 | 64.09 | 48139232–48129734 | Mark370122–Mark383650 | 0.08 | 9.23 | NS | NS | NS | 0.1 | [3] | ||
qSW-4-3ZY | 4 | 13.9 | 3681724–5115633 | Mark411964–Mark375360 | 0.13 | 25.78 | NS | NS | −0.01 * | 0.25 | [3] | ||
qSW-6-1ZY | 6 | 23.63 | 6820998–6873235 | Mark743934–Mark764418 | 0.07 | 6.39 | NS | 0.05 ** | −0.05 ** | 4.15 | [32] | ||
qSW-9-3ZY | 9 | 58.19 | 30576094–33868843 | Mark584128–Mark577210 | 0.04 | 2.86 | NS | NS | NS | 0 | THIS STUDY | ||
qSW-13-3ZY | 13 | 80.04 | 32094249–32215414 | Mark487690–Mark477270 | 0.09 | 12.55 | −0.01 * | 0.03 ** | −0.02 ** | 1.67 | THIS STUDY | ||
qSW-17-3ZY | 17 | 26.12 | 5914087–5923952 | Mark80080–Mark102449 | 0.07 | 6.28 | 0.03 ** | NS | −0.02 ** | 1.4 | [3] | ||
qSW-20-1ZY | 20 | 82.14 | 41039353–41758780 | Mark244793–Mark230802 | 0.04 | 2.48 | NS | NS | −0.01 * | 0.16 | THIS STUDY | ||
ST | qST-1-3ZY | 1 | 66.15 | 24564849–25434623 | Mark988529–Mark966630 | 0.06 | 3.58 | NS | NS | NS | 0 | THIS STUDY | |
qST-4-2ZY | 4 | 44.13 | 30867521–32458924 | Mark404804–Mark410274 | 0.06 | 3.43 | 0.01 ** | NS | −0.02 ** | 0.47 | [3] | ||
qST-6-4ZY | 6 | 28.98 | 8734791–8864415 | Mark778253–Mark768262 | 0.09 | 7.87 | NS | NS | NS | 0 | THIS STUDY | ||
qST-13-4ZY | 13 | 74.5 | 29909876–29933390 | Mark492165–Mark480651 | 0.08 | 6.47 | −0.04 ** | 0.02 ** | 0.01 ** | 1.31 | [33] | ||
qST-17-3ZY | 17 | 26.12 | 5914087–5923952 | Mark80080–Mark102449 | 0.08 | 5.27 | NS | NS | NS | 0.03 | [3] | ||
qST-18-2ZY | 18 | 73.25 | 11452216–56974484 | Mark107824–Mark1041506 | 0.14 | 17.36 | NS | NS | NS | 0 | THIS STUDY | ||
qST-20-1ZY | 20 | 46.1 | 32964872–34278811 | Mark222598–Mark260922 | 0.09 | 6.68 | NS | NS | NS | 0 | [33] | ||
SLW | qSLW-6-3ZY | 6 | 68.61 | 39116570–39478973 | Mark735467–Mark752696 | 0.02 | 16.59 | NS | NS | NS | 0.02 | [33] | |
qSLW-9-2ZY | 9 | 26.46 | 5253206–5593340 | Mark586124–Mark605515 | 0.02 | 6.23 | NS | NS | NS | 0.01 | THIS STUDY | ||
qSLW-10-1ZY | 10 | 34.22 | 40118012–41534124 | Mark647482–Mark674118 | −0.01 | 3.59 | NS | NS | NS | 0.22 | THIS STUDY | ||
qSLW-14-1ZY | 14 | 2.62 | 46512262–46896487 | Mark910347–Mark906347 | −0.03 | 3.59 | NS | NS | −0.01 | 0.22 | THIS STUDY | ||
SLT | qSLT-2-2ZY | 2 | 54.96 | 13892893–14031565 | Mark45679–Mark24395 | −0.04 | 14.3 | NS | NS | NS | 0 | THIS STUDY | |
qSLT-6-5ZY | 6 | 72.26 | 43230405–43114475 | Mark747633–Mark770074 | 0 | 7.18 | NS | NS | NS | 0 | [34] | ||
qSLT-8-3ZY | 8 | 107.06 | 44543723–45326890 | Mark457232–Mark423205 | 0.03 | 8.95 | NS | NS | NS | 0 | THIS STUDY | ||
qSLT-10-1ZY | 10 | 34.22 | 40118012–41534124 | Mark647482–Mark674118 | −0.03 | 8.65 | NS | NS | NS | 0 | THIS STUDY | ||
qSLT-10-2ZY | 10 | 3.31 | 4454862–4625724 | Mark637694–Mark659817 | 0.03 | 9.56 | NS | NS | NS | 0 | [34] - | ||
qSLT-14-2ZY | 14 | 118.74 | 27709972–27836278 | Mark905511–Mark937850 | −0.02 | 4.16 | NS | NS | NS | 0 | THIS STUDY | ||
qSLT-17-1ZY | 17 | 12.06 | 3433165–1091815 | Mark91398–Mark70303 | −0.02 | 3.77 | NS | NS | NS | 0 | [33] | ||
qSLT-18-1ZY | 18 | 72.71 | 11452216–56974484 | Mark107824–Mark1041506 | −0.04 | 3.77 | NS | NS | NS | 0 | THIS STUDY | ||
SWT | qSWT-2-2ZY | 2 | 45.8 | 10992717–11277233 | Mark4308–Mark33823 | −0.04 | 3.72 | NS | NS | NS | 0 | THIS STUDY | |
qSWT-8-3ZY | 8 | 111.68 | 45326630–45114110 | Mark466182–Mark457232 | 0.01 | 4.91 | NS | NS | NS | 0 | THIS STUDY | ||
qSWT-13-3ZY | 13 | 118.22 | 39676002–42053780 | Mark492087–Mark510247 | −0.01 | 4.03 | NS | NS | NS | 0.36 | [34] | ||
qSWT-14-1ZY | 14 | 132.78 | 43567951–44159326 | Mark927308–Mark890844 | −0.01 | 3.64 | NS | NS | NS | 0.01 | THIS STUDY | ||
qSWT-18-1ZY | 18 | 73.25 | 56974254–11452436 | Mark107824–Mark1041506 | −0.03 | 18.77 | NS | NS | NS | 0.79 | THIS STUDY | ||
K3N | SL | qSL-17-3K3N | 17 | 118.01 | 40207655–41906774 | bin1466–bin1467 | 0.08 | 5.71 | NS | NS | NS | 0 | THIS STUDY |
qSL-20-1K3N | 20 | 55.91 | 36184890–36777026 | bin1698–bin1699 | −0.09 | 6.72 | NS | −0.01 * | 0.03 ** | 1.02 | THIS STUDY | ||
ST | qST-10-1K3N | 10 | 59.22 | 36682803–37647030 | bin827– | −0.08 | 7.05 | −0.03 ** | 0.02 ** | 0.02 ** | 2.06 | THIS STUDY | |
bin829 | |||||||||||||
SLW | qSLW-5-2K3N | 5 | 94.46 | 38132148–38801307 | bin402– | −0.01 | 7.06 | NS | NS | NS | 0.01 | [34] | |
bin403 | |||||||||||||
qSLW-16-1K3N | 16 | 69.6 | 32318950–33186025 | bin1362–bin1363 | −0.01 | 2.2 | NS | NS | NS | 0.02 | [34] | ||
SLT | qSLT-16-1K3N | 16 | 75.68 | 33853674–35244129 | bin1371–bin1372 | −0.04 | 19.15 | NS | −0.01 * | NS | 1.49 | THIS STUDY | |
qSLT-20-1K3N | 20 | 68.27 | 37878839–38300982 | bin1704–bin1705 | −0.03 | 11.77 | NS | NS | NS | 0.05 | THIS STUDY |
Chr.: chromosome. * p < 0.05 and ** p < 0.01. PVE indicates phenotypic variation expressed by additive effects. AE1: 2012FY, AE2: 2012JP, and AE3: 2017JP.